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Abstract: Background: Primary dysmenorrhea is a common condition in women of reproductive age.
A previous app-based study undertaken by our group demonstrated that a smartphone app supporting
self-acupressure introduced by a health care professional can reduce menstrual pain. Objective: This
study aims to evaluate whether a specific smartphone app is effective in reducing menstrual pain in 18-
to 34-year-old women with primary dysmenorrhea in a self-care setting. One group of women has access
to the full-featured study app and will be compared with 2 control groups who have access to fewer app
features. Here, we report the trial design, app development, user access, and engagement. Methods: On
the basis of the practical implications of the previous app-based study, we revised and reengineered the
study app and included the ResearchKit (Apple Inc) framework. Behavior change techniques (BCTs)
were implemented in the app and validated by expert ratings. User access was estimated by assessing
recruitment progress over time. User evolution and baseline survey respondent rate were assessed to eval-
uate user engagement. Results: The development of the study app for a 3-armed randomized controlled
trial required a multidisciplinary team. The app is accessible for the target population free of charge
via the Apple App Store. In Germany, within 9 months, the app was downloaded 1458 times and 328
study participants were recruited using it without external advertising. A total of 98.27% (5157/5248)
of the app-based baseline questions were answered. The correct classification of BCTs used in the app
required psychological expertise. Conclusions: Conducting an innovative app study requires multidis-
ciplinary effort. Easy access and engagement with such an app can be achieved by recruitment via
the App Store. Future research is needed to investigate the determinants of user engagement, optimal
BCT application, and potential clinical and self-care scenarios for app use. Trial registration: Clini-
calTrials.gov NCT03432611; https://clinicaltrials.gov/ct2/show/NCT03432611 (Archived by WebCite at
http://www.webcitation.org/75LLAcnCQ).
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Background: Primary dysmenorrhea is a common condition in women of reproductive age. A previous app-based study
undertaken by our group demonstrated that a smartphone app supporting self-acupressure introduced by a health care professional
can reduce menstrual pain.
Objective: This study aims to evaluate whether a specific smartphone app is effective in reducing menstrual pain in 18- to
34-year-old women with primary dysmenorrhea in a self-care setting. One group of women has access to the full-featured study
app and will be compared with 2 control groups who have access to fewer app features. Here, we report the trial design, app
development, user access, and engagement.
Methods: On the basis of the practical implications of the previous app-based study, we revised and reengineered the study app
and included the ResearchKit (Apple Inc) framework. Behavior change techniques (BCTs) were implemented in the app and
validated by expert ratings. User access was estimated by assessing recruitment progress over time. User evolution and baseline
survey respondent rate were assessed to evaluate user engagement.
Results: The development of the study app for a 3-armed randomized controlled trial required a multidisciplinary team. The
app is accessible for the target population free of charge via the Apple App Store. In Germany, within 9 months, the app was
downloaded 1458 times and 328 study participants were recruited using it without external advertising. A total of 98.27%
(5157/5248) of the app-based baseline questions were answered. The correct classification of BCTs used in the app required
psychological expertise.
Conclusions: Conducting an innovative app study requires multidisciplinary effort. Easy access and engagement with such an
app can be achieved by recruitment via the App Store. Future research is needed to investigate the determinants of user engagement,
optimal BCT application, and potential clinical and self-care scenarios for app use.
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Introduction
Background
In recent years, increasing smartphone access has enabled the
advancement and widespread use of smartphone apps [1,2].
Apps are a promising tool for people with a wide variety of
health conditions and may be particularly useful to guide and
support individuals in the self-management of these conditions
[3,4]. A recent systematic review on apps in pain management
concluded that apps might be beneficial for patients, particularly
in an outpatient setting, but that there is a need for more
scientific knowledge [5]. Furthermore, in an Australian national
survey on mobile health (mHealth) in women with polycystic
ovary syndrome [6], current evidence-based information was
considered to be the most desirable app feature. Thus, an app
with evidence-based information on menstrual pain might be
of great value for patients suffering from this common problem.
Menstrual disorders are highly prevalent among women of
reproductive age, and especially in young women; they
commonly include period pain and mood disturbances [7].
Primary dysmenorrhea is defined as menstrual pain in the
absence of underlying pathology, with the pain commonly
starting within 3 years of menarche (the first menstrual period)
[8]. A characteristic symptom of primary dysmenorrhea is
crampy, colicky spasms of pain below the belly button,
occurring within 8 to 72 hours of menstruation and peaking
within the first few days as menstrual flow increases [9]. Many
women with dysmenorrhea also experience other
menstrual-related symptoms such as back pain, headaches,
bowel changes, nausea, and vomiting [9]. Primary dysmenorrhea
has significant negative impacts on education [7] and
productivity at work [10]. Current menstrual health literacy and
understanding of effective self-care strategies for menstrual
symptoms are often poor [11].
In a previous randomized pragmatic trial (trial registration:
ClinicalTrials.gov NCT01582724) [12] for women with
menstrual pain, a total of 221 women were randomly assigned
to 1 of 2 study groups. Both groups received the study app and
a short introduction by a health care professional. Although the
intervention group had access to acupressure-based features,
including visual and written instructions on how to apply
self-acupressure before and during menstruation, the control
group did not. In addition, the app could send regular reminders
to start the acupressure or to fill in questions. For both groups,
the app was used to collect the study-related data and support
the management of the menstrual period with a simplistic period
calendar. Users in the self-acupressure group reported a
significant reduction in the mean pain intensity and reported
less pain medication intake in comparison with the usual care
control group. In addition, two-thirds of the women still used
the app and continued to apply self-acupressure after 6 months
[12]. Owing to the fast-developing mHealth technology, it was
difficult to keep these noteworthy study results relevant for
actual implementation. This was, in part, because of the user
experience and because the underlying technology soon became
outdated. Therefore, a complete modernization and
reengineering of the app and the development of a new
corresponding trial that examines its effect over a longer
duration than undertaken in the initial trial were necessary.
In 2015, Apple Inc introduced ResearchKit as an open-source
framework to support clinical researchers conducting structured
mobile app–based health studies [1]. This free and reusable
framework can simplify the integration of patient recruitment,
the consent process, and the data collection in an mHealth study
app. A modernization and reengineering of the previous study
app using the ResearchKit framework, new software tools, and
design guidelines for broader functionalities and an up-to-date
interface would allow to verify the study results from our
previous trial on a larger scale and in a real-life self-care setting
in several different countries across the world. To our
knowledge, no ResearchKit app-based interventional studies
have been previously conducted targeting women with menstrual
pain. By implementing this ResearchKit app, it would be
possible to improve self-care for menstrual pain by encouraging
users to change their behavior and regularly apply self-care
activities, such as exercise, yoga, or self-acupressure.
Michie et al defined the smallest, observable, replicable
intervention component with the potential to bring about change
in behavior as behavior change techniques (BCTs) [13]. BCTs
have been widely applied in electronic health interventions. A
prior ResearchKit app-based observational study evaluated the
decision making in patients with acute anterior cruciate ligament
ruptures [14] and suggested that it might be possible to maintain
users’ motivation by providing instant feedback and relevant
treatment information. In another study aimed at reducing
alcohol consumption via an app [15], self-monitoring, goal
setting, action planning, and feedback in relation to goals were
identified as BCTs with the greatest potential to reduce alcohol
use. A review on apps targeting persons with poor control of
type 2 diabetes mellitus also suggests that the majority of BCTs
employed are those for the promotion of self-regulatory behavior
[16]. However, there is a lack of data for expert validation of
BCTs implemented in apps for menstrual pain.
From the recruitment perspective, previous ResearchKit-based
studies predominantly used Web-based recruitment. Web-based
recruitment has the potential advantage of reaching a broader
population quickly, whereas conventional recruitment is usually
time consuming and costly. However, the broad reach can
potentially bring in people who are not the target population of
a particular mHealth study [17]. In an interventional ResearchKit
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study, enrollment before eligibility screening (number of App
Store visits and downloads) and after baseline questions are
indicators for user engagement. However, this important
measurement has not been widely reported in previous mHealth
studies yet.
Objectives
To address the questions raised above and to gain a greater
understanding for conducting mHealth trials, we report the
development, user access, and user engagement of our
ResearchKit-based study app for an ongoing pragmatic
randomized controlled trial (RCT) [18] on menstrual pain.
Methods
Study App and Study Design
Technical Development of the Study App
The development of the app was started with the aim to
modernize the design and technology of the study app AKUD
(2012-2015) for a new 3-armed study in a self-recruitment
self-care setting.
The study app Luna. (Luna, period) was developed in a
collaborative project by the Institute of Complementary and
Integrative Medicine of the University of Zurich, Switzerland,
the Institute for Social Medicine, Epidemiology and Health
Economics, Charité – Universitätsmedizin Berlin, Germany,
and Smart Mobile Factory, Berlin, Germany, based on Apple’s
ResearchKit modular concept. The app was coded in Swift 4
with initial full support for English and German and prepared
for easy deployment of other languages, such as simplified and
traditional Chinese. The design followed the iOS Human
Interface Guidelines (2017) and targets young women. The team
involved in the development included iOS and back-end
developers, designers, medical doctors, public health
researchers, psychologists, and experts on integrative medicine
and health.
Behavior Change Techniques in the Study App
The development of user interaction and feedback wording was
based on the previous app. However, during the development
of the new app, we used the BCT taxonomy (BCTTv1),
according to Michie et al [19], to document BCTs employed in
the app. For example, the BCT goal setting was implemented
to promote the goal of completing certain self-care activities.
In addition, bar charts that recorded change in pain and activities
were set up based on the BCT self-monitoring. The app was
developed in English. During the adaption to German and
Chinese, the content of the app was always translated with care
to ensure that the respective underlying BCTs were not affected.
For the scientific description of an mHealth intervention, a
proper description of BCTs implemented in the app is important.
For this, expert validation is essential. At a later stage after the
app development was completed, 2 psychologists who were not
part of the development team independently rated the individual
app features to validate the proper use of BCTs according to
the BCTTv1 [19]. We compared the list of BCTs (that were
intended to be implemented in the app) of 1 app development
team member with the rating results of these 2 psychologists.
Where there was disagreement regarding which BCT was used
in the app, a final agreement was reached in a consensus meeting
between the 3 raters (Table 1).
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Table 1. App features and corresponding behavior change techniques implemented.
BCTsa (rating)Wording and app contentApp features
No BCTs“Hello! To get to know you better, we would like to ask
you some more questions. All of your data will be kept
strictly confidential and anonymous.”
Introduction to baseline survey
No BCTs“Thank you for your patience. Now we have all the nec-
essary baseline information. You can start with the study.”
Baseline survey finished
Prompts/cues (7.1)“Time to do some activities for your period pain and
record your progress.”
Notification of doing interven-
tions/fulfilling surveys
Social reward (10.4)“Well Done!”When a survey has been finished
Prompts/cues (7.1)“Missing Answers. Keep going with the questions, this
can help you see your progress.”
In-app reminder of finishing survey
during task days
Prompts/cues (7.1)“Apply acupressure. On days where you have pain, we
recommend at least twice a day.”
In-app reminder for acupressure
Social reward (10.4)“Well Done! Keep on taking care of yourself.”When the timer for acupressure fin-
ished (for all 6 points)
Prompts/cues (7.1)“New questions will appear five days before your next
period.”
Guide for nontask days
Goal setting (behavior) (1.1); action planning (1.4)When to Apply Acupressure. Instructions of when to ap-
ply acupressure (time, frequency).
Instructions of when to apply acu-
pressure
Instructions on how to perform a behavior (4.1)How to Apply Acupressure. Instructions of how to apply
acupressure (position, strength, and feeling).
Instructions of how to apply acupres-
sure
Instructions on how to perform a behavior (4.1);
demonstration of behavior (6.1)
Image and description of locations of acupressure 3
points: spleen 6, liver 3, large intestine 4.
An image and location for each
acupressure point
Instructions on how to perform a behavior (4.1);
demonstration of behavior (6.1)
An instruction animation for self-acupressure on 3 points:
spleen 6, liver 3, large intestine 4.
Instruction video for self-acupres-
sure
Information about health consequences (5.1); credible
source (9.1)
“Evidence-based information with references of 5 self-
care recommendations: exercises; dietary supplementa-
tions; heating pad/hot water bottle; yoga; medication.”
Self-care recommendation
Goal setting (behavior) (1.1); instructions on how to
perform a behavior (4.1); demonstration of behavior
(6.1)
A counting down timer with a picture of the corresponding
acupressure point.
Timer for self-acupressure: 1 minute
for each point
Feedback on behavior (2.2); self-monitoring of be-
havior (2.3); self-monitoring of outcome(s) of behav-
ior (2.4); feedback on outcome(s) of behavior (2.7)
Dashboard screen, including period calendar, diagrams,
and charts reviewing pain and survey questions, and a
function button for period start/end.
Dashboard screen
Prompts/cues (7.1)Journal screen in calendar view, including period calendar
that also displays the completion of survey questions.
Journal screen: calendar
No BCTsJournal screen in questions view, including a list of survey
questions with the date.
Journal screen: questions
No BCTsSelf-care screen, including a list and icon images for 5
self-care recommendations.
Self-care screen
aBCT: behavior change technique.
Privacy and Data Security
Privacy and data security were considered high priorities during
app development. User data collected by the app are encrypted
and transferred anonymously. We adhere to the principle of
data minimization [20] and collect only data that are absolutely
necessary to answer the research questions. Personally
identifiable information (PII), such as the name and signature
collected during the informed consent procedure provided by
Apple ResearchKit, is stored only on the user’s iPhone and will
not be sent to the back end. The individual person owning the
iPhone (the study participant) will not be identifiable by the
data transferred to the study server. A token will be created as
an identifier to label the individual study data. Moreover, an
app passcode is implemented to avoid unintended access to the
app. Collection of information by the app can be stopped at any
time by withdrawing from the study, using a specific button in
the app’s settings, and uninstalling the app. Data will be
collected anonymously. In addition, the study team of the
coordinating office in Germany is supervised by the data
protection officer of the Charité—Universitätsmedizin Berlin.
The other participating centers are supervised by their respective
institutions.
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We will conduct a 3-armed, randomized pragmatic trial [18,21]
to evaluate whether the smartphone app is effective in reducing
menstrual pain in 18- to 34-year-old women with primary
dysmenorrhea. We will compare the group of women who has
access to the full-featured study app with 2 control groups who
have access to fewer app features. After within-app verification
of eligibility for the study, eligible women will be randomly
allocated to one of the 3 groups in a 1:1:1 ratio. The potential
group allocations are as follows: full-featured app version
(self-care information + self-acupressure feature), control
intervention I (only self-care information feature), or control
intervention II (only self-acupressure feature). The app contains
the interventions for all 3 groups, but the content is only
unlocked and presented to the user depending on their group
allocation. Study participants can use the app for the whole
study duration of 12 menstruation cycles. The primary outcome
of the study is the mean pain intensity measured with the in-app
numerical rating scale (NRS) ranging from 0, no pain, to 10,
most intense pain imaginable, on the painful days during the
sixth menstruation after starting the intervention (approximately
6 months from trial start depending on cycle length). It will be
calculated by adding up the daily values from the start of the
menstruation until the end of bleeding and then dividing them
by the number of days with available values. NRS is a common
measure of pain intensity that has been utilized in many previous
studies [22-24], including studies of menstrual pain [25,26].
Secondary outcome measures are described in more detail on
ClinicalTrials.gov (NCT03432611).
The decisions on study design of this trial are based, in part, on
decisions of the stakeholder advisory group from the
corresponding previous trial and its results [12]. As no member
of the study team was specialized in gynecology, this expertise
was represented by a gynecologist appointed to the advisory
group. Our stakeholder advisory group included a female
gynecologist, a 16-year-old woman with dysmenorrhea, a female
teacher, 2 acupuncture experts, and a mind-body medicine expert
[27].
Intervention Components
Furthermore, 5 days before the anticipated start of the
menstruation until the end of bleeding, notifications from the
app will remind all the groups of participating women to
complete questions and perform self-care activities, such as
self-acupressure or yoga, depending on the group allocation.
The self-care feature will offer information on self-care for
menstrual pain, including evidence-based information about
exercise, nutrition and dietary supplementation, heating pad/hot
water bottle, yoga, and when to consult a doctor and regarding
how primary dysmenorrhea is treated in most cases (see
Multimedia Appendix 1).
The acupressure feature will offer detailed written and
multimedia descriptions of the acupressure to be used for
menstrual pain (see Multimedia Appendix 2). A total of 3
acupressure points will be described that should be massaged
bilaterally, if possible, twice a day, up to 5 times per day,
starting from 5 days before menstruation until the end of
menstruation. Each point should be massaged for 1 min (ie,
altogether 6 min should be spent for 1 acupressure session). A
visual timer for the acupressure will indicate desirable length
of acupressure. In addition, an in-app notification on the app’s
dashboard will remind users to practice acupressure during
painful days at least twice daily.
The acupressure intervention resulted from a written consensus
process with international acupuncture experts from China,
Germany, and the United States of America [27] and was already
evaluated in an RCT previously conducted by our group
demonstrating effectiveness of the intervention [12]. The
acupuncture points SP6 (Sanyinjiao), LI4 (Hegu), and LR3
(Taichong) were chosen during this process.
Participants are allowed to continue with their own usual care
(medical and nonmedical) during the study.
Participants and Group Allocation
We aim to recruit 594 young women with primary
dysmenorrhea. The sample size estimation is based on the
comparison of the group receiving the full-featured app
(self-care information + self-acupressure) with the group
receiving the app version without the self-care information
(control intervention II) regarding the primary outcome (NRS
after 6 menstrual cycles) that will be treated as a continuous
variable. Our previous study showed a mean group difference
of 1.4 on the NRS and a standard deviation of 2.15 at the sixth
menstrual cycle after the onset of the trial.
Assuming that self-care information has a smaller impact on
pain than acupressure, we hypothesize a difference of 0.8 on
the NRS between groups. To detect a mean difference of 0.8
point on the NRS after 6 menstrual cycles between the group
receiving the full-featured app (with a common standard
deviation of 2.15 observed in our previous study) and control
intervention II, applying a 2-sided t test with a power of 80%
and an adjusted alpha of .025, a total of 139 participants will
be needed per group (417 women for the 3 arms together).
Taking into account a dropout rate of approximately 30% (based
on our previous study after 6 cycles), 198 participants per group
will be needed (total 594 women).
The eligibility criteria resemble the criteria of our previous
study. Women owning an iPhone will be included if they have
primary dysmenorrhea, are between the ages of 18 and 34 years,
report moderate or severe menstrual pain ≥6 on the NRS; 0=no
pain at all, 10=most intense pain imaginable), and report no
existing or planned pregnancy within the next 12 months. During
the app-based eligibility screening, the inclusion and exclusion
criteria will be assessed by 12 compulsory eligibility questions
(Table 2). After the determination of eligibility and obtaining
informed consent, participants will be asked to complete the
baseline survey before they receive access to the app features
depending upon the respective study group allocation. We will
use a server-based randomization table created by a statistician
using the RANUNI random number generator of the SAS/STAT
version 9.2 (SAS Inc) [28]. Participating women will be
randomized in a 1:1:1 ratio by block randomization with a fixed
block length.
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Table 2. Eligibility questions.
CriteriaQuestion typeEligibility questions
If no, excludeYes/noAre you a woman over 18 and below 35 years old?
If no, excludeYes/noDo you suffer from period pain or menstrual cramps during every menstrual
cycle?
If yes, excludeYes/noDo you suffer from your period pain on more than 5 days outside the pe-
riod?
If no, excludeYes/noDo you think your pain started during your teenage years?
If yes, excludeYes/noDo you have any prior history of a gynecological disease that is known
to be a reason for your period pain?
If no, excludeYes/noDid you have a period within the last 6 weeks?
If no, excludeYes/noIs your cycle length between 3 and 6 weeks?
If <6, excludeNumerical on a pain
scale from 0 to 10
How strong was the most severe pain without medication during your last
period?
If no, excludeYes/noAre you willing to see a doctor when (1) your pain is getting worse than
usual, (2) pain medication is not helping, and (3) when you have pain well
before or well after the period?
If yes, excludeYes/noAre you pregnant?
If yes, excludeYes/noDo you plan to be pregnant within the next 12 months?
If no, exclude and message the user because of
data protection, the app should be used only on
your own iPhone
Yes/noIs this your iPhone?
Efficacy-Effectiveness Continuum
From a methodological point of view, a clinical trial provides
more evidence on the effectiveness of an intervention using a
pragmatic trial design or on the efficacy side using an
explanatory trial design [29,30]. Pragmatic trials are usually
considered to study interventions in a real-world setting, whereas
explanatory trials are usually designed to investigate
interventions in an ideally controlled setting. The PRECIS-2 is
a wheel-format tool that helps researchers to consider trial design
as more effectiveness or efficacy focused including 9 domains:
eligibility criteria, recruitment, setting, organization, flexibility
(delivery), flexibility (adherence), follow-up, primary outcome,
and primary analysis [31]. The PRECIS-2 scoring system ranges
from 1 (most explanatory) to 5 (most pragmatic).
During the design phase of the trial, PRECIS served as a tool
to make better informed design decisions [32]. We used the
PRECIS-2 tool to assess our app-based trial’s positioning on
the pragmatic-explanatory continuum. The authors
independently scored the 9 dimensions.
User Enrollment
The primary recruitment strategy focuses on self-referral through
the Apple App Store. On the basis of our experience from the
previous trial and the associated stakeholder engagement
[12,27], we anticipate that an app-based study for menstrual
pain would meet wide acceptance among young women in
Germany. Furthermore, we assume that no external advertising
(such as posters in public transport or on campus) will be needed
for recruitment. A Web-based press release on the Charité
university homepage was published on February 28, 2018, (in
German and English language), highlighting the results of the
previous trial, while also mentioning the new study with the
updated app, including a link to the App Store. The media
coverage of the app is observed regularly by the study team,
using Google search with keywords “selfcare + period pain +
Luna,” “selfcare + Luna,” “app + period pain,” “acupressure +
period pain” (in German: “Selbsthilfe + Regelschmerzen +
Luna,” “Selbsthilfe + Luna,” “app + Regelschmerzen,”
“Akupressur + Regelschmerzen”).
The app use will be free of charge; no financial compensation
will be provided for participating in the study.
Potential future recruitment strategies will include traditional
and Web-based recruitment methods that are also adapted to
the respective study sites. These will include information about
the ongoing study on printed posters or information leaflets or
in social media. In addition, if accepted by the Apple App Store
editorial team, we will inform potential users about the study
app with the App of the day feature option of the Apple App
Store for the category Health and Fitness.
User Engagement
When users install and open the study app for the first time,
they will be briefly introduced to the study and encouraged to
participate. For potential participants who wish to continue, an
app-based anonymous eligibility screening and more detailed
information about the study will be provided. After the consent
process, participants will finish the app-based baseline survey
to unlock the intervention interface. This process is based on
the onboarding process of Apple’s ResearchKit framework [33].
User flow and conversion rates will be calculated based on the
number of downloads, the number of eligible users, and the
number of users who finish the baseline survey and enter the
study.
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In the baseline survey, general information relevant for
menstrual pain will be assessed, such as age, education,
individual exercise behavior, length of period and level of pain
experienced during the period, and use of hormonal
contraceptives and pain medications (Table 3). A skip button
is available for a selection of questions and allows users to skip
questions they do not want to answer. User engagement will be
measured by usage of skip button and baseline survey respondent
rate.
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Table 3. Baseline questions.




XBMI calculated from height and weight
Your height: ____ cm
Your body weight: ____ kg
XWhat is the highest level of education you have completed so far?
High school or above
Other
—
bHow long is your cycle usually (the time from the first day of period until the beginning of the next period)?
_____ days
—How long is your period usually?
_____ days
XWhat kind of period pain and discomfort do you usually experience? (multi-choice possible)
Stomach cramps




Other symptoms, namely _____





If yes, why do you use hormonal contraceptives?
I use hormonal contraceptives because of my period pain.
I use hormonal contraceptives for contraception.
I use hormonal contraceptives because of other reasons (for example, acne).
If yes, which hormonal contraceptives are you using? ______
If yes, how long have you been using hormonal contraceptives? for ____ months and ____ years
XHave you ever been pregnant?
No
Yes
If yes, number of pregnancies:____
If yes, number of births:____
—How intense was the average period pain of the painful days during your last period?
0 1 2 3 4 5 6 7 8 9 10 (0=no pain at all, 10=most intense pain imaginable)
—During your last period, how intense was the worst period pain you experienced?
0 1 2 3 4 5 6 7 8 9 10 (0=no pain at all, 10=most intense pain imaginable)
XOn how many days have you had period pain during your last period?
_____ days
XOn how many days were you absent from work or education due to period pain during your last period?
_____ days
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Skip buttonBaseline questions and answer field
Have you taken any medication for your period pain?
XNo
Yes ->if yes, which one: ______





























—When did you have your last period? Please enter the data of the first day of your last period.
__.__.____
aX: skip button enabled.
b—: skip button disabled.
cIUD: intrauterine device.
Statistical Analysis
The PRECIS-2 score was calculated by summing up the means
of each dimension based on the rating results of 11 raters;
meanwhile, standard deviations were calculated to show the
variability.
For the BCT ratings, the interrater reliability among BCT raters
was assessed by intraclass correlations (ICCs) [34,35].
For the assessment of user access, we used the data generated
by App Analytics [33] (Apple Inc) to descriptively show the
source of product page views and number of downloads.
To assess user engagement, the user conversion rate and the
baseline survey response data were calculated using descriptive
statistics (frequencies, percentages, means, and standard
deviations). The baseline survey variables were extracted from
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the back-end database and only the missing values of the
baseline survey (skipped questions) were used for the calculation
of the proportion of actually skipped questions among all
skippable questions to interpret the user engagement.
All collected data were analyzed with SPSS version 22.0 (SPSS
Inc).
Ethics
The app is prepared for international use and can be currently
(October 2019) downloaded in the German App Store and will
later be made available in the App Stores of the other
participating centers. The study database, the app server, and
the primary study center are based in Berlin, Germany. The
study was approved by the university’s ethics committee
(Charité—Universitätsmedizin Berlin approval Number
EA1/364/16). The trial was registered at ClinicalTrials.gov
(NCT03432611).
The participation of the study sites in Taichung, Taiwan
(approval letter Number CMUH107-REC1-120 by Ethics
Committee of China Medical University and Hospital); Sydney,
Australia (approval number H13175 by Western Sydney
University Human Research Ethics Committee); Florianopolis,
Brazil (approval number 3.583.066 by Ethics Committee of
Federal University of Santa Catarina), and Baltimore, United
States is currently being processed.
Results
Study App and Study Design
The study app is a result of multidisciplinary efforts. The launch
of the study app in the App Store will mark the beginning of
the fully app-based study: users will be recruited via the Apple
App Store, eligibility and consent will be processed by the study
app, different self-care interventions will be guided by
corresponding app features, and the follow-up will be recorded
by app-based survey questions (Figure 1). Detailed screenshots,
which depict the user flow in more detail, are listed in
Multimedia Appendix 3.
The study app will display the intervention components
(self-acupressure and self-care information) selectively
according to the group allocation. The core features Dashboard,
Journal, and More (Figure 2) will be accessible to all users.
The Dashboard will display feedback according to study
progress and answers of survey questions and a prediction of
the next period start date. The Journal feature will contain a
period calendar and an overview of the progress on the survey
questions. With the More feature, users will be able to set
personal identification number lock and notification time. Users’
cycle information, the signed consent form, and a link to the
privacy policy will also be displayed there.
Figure 1. Study design. ITT: intention to treat; PP: per protocol.
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Figure 2. Screenshots of the study app.
Behavior Change Technique Ratings
To validate whether the BCTs implemented in the app were
properly applied, a developer rating (JW) was compared with
ratings of 2 psychologists with BCT expertise (CRP and AR)
who had experienced the finalized full-featured app but who
had not been part of the app development process. The interrater
agreement between the 2 psychologists showed an excellent
ICC (ICC=0.954; 95% CI 0.87-0.98). However, the overall
interrater agreement including all raters was poor (ICC=0.442;
95% CI 0.07-0.78), that is, the ratings of the BCTs used during
the development by the study team, did not correspond well
with the ratings of the 2 psychologists. There was no significant
difference between ICCs at the item level and the cluster level
based on the BCTs taxonomy (v1) [19]. The final agreement
that was reached in a consensus meeting is shown in Table 2.
Overall, 12 BCTs were identified in the study app. The most
frequently implemented BCTs are prompts/cues (5 times),
instructions on how to perform behavior (4 times), and
demonstration of the behavior (3 times).
Efficacy-Effectiveness Continuum Rating
On the basis of the rating results of all authors, all 9 dimensions
of the PRECIS-2 tool are defined more on the pragmatic side
(Figure 3). Thus, this app-based RCT can be considered as a
pragmatic trial.
Figure 3. PRECIS-2 rating results of the study design.
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Trial recruitment started in February 2018 with the launch of
the ResearchKit-based study app in the German App Store. The
Web-based press release was well received by the public and
the media. By observation of media coverage via Google search
during the following 10 weeks, 65 articles or blog entries of
pharmacy or health-related websites citing the press releases in
English and German could be detected. Overall, 2 printed
newspapers reported about this app-based study in German. An
increase of media coverage could be observed from March to
May 2018. In the weeks following the press release, the app
showed continuous increase in both downloads and the number
of users (Figure 4).
After 38 weeks in the app store (from February 19, 2018, to
November 13, 2018), there were 1458 downloads and 328 users
were included into the study (22.5%). On average, we recruited
around 8 study participants per week with a peak between May
and June after the press release (22 new users per week).
Approximately 60% (195/328) of the participants were recruited
within these 2 months.
Figure 4. App downloads and new users per day.
User Engagement
During the first 38 weeks of recruitment, the App Store’s
preview of the app was viewed 1885 times. Although 75% of
the app’s product page viewers found the app by searching the
App Store, 25% found the app by App Store browsing, app
referral, or Web referral. The app was downloaded 1458 times.
A total of 388 (27%) users passed the 12-question eligibility
screening and agreed to consent; 328 of the 388 users (85%)
completed the 16-question baseline survey and were recruited
to the study. Figure 5 displays the user evolution [14].
For 11 of 16 baseline questions, the skip button can be used
because these questions are either not related to the primary
outcome of the study or their data are not essential for the proper
functioning of the app. The usage of the skip button of a study
sample (328 users) was calculated to evaluate the user
engagement in the app-based survey.
Almost all questions of the baseline survey were answered (data
completeness of 98.27%; 5157/5248). A total of 276 users
(276/328, 84.1%) answered all 16 baseline questions and never
used the skip button. Only 3% of the data based on the skippable
questions were missing. The question asking for
discomfort/symptoms during the period was answered by all
users (response rate 100%). For free-text fields, 105 (105/328,
32.0%) of the users provided details about their
discomfort/symptoms during their period; 269 (269/328, 82.0%)
users provided details about their medication for the question
asking about the period pain-related medical history.
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Figure 5. User evolution.
Discussion
Principal Findings
By using the ResearchKit framework, we successfully developed
a study app for a fully app-based pragmatic RCT for young
women with primary dysmenorrhea. The app is easily accessible
via self-referral and can be used as a self-care and study tool
for a highly relevant condition. The available data already
indicate a high level of user engagement with the study app.
We also realized that the early involvement of behavioral science
experts is of great importance for the development of app-based
trials.
In a young population that widely uses smartphones, a digital
intervention, such as the study app, provides low entry barriers.
It offers easy access to evidence-based self-care information
for menstrual pain and tools to improve healthy behavior. We
believe that recruitment is not only influenced by the app itself
but also by the way of communicating the study. We observed
a substantial increase in recruitment rates following the
publication of a press release on our university’s websites and
corresponding media coverage. A causal relationship in the
recruitment increase seems to be very probable. After 5 months
without actively communicating the study with media or
information material, we still could observe a basic recruitment
of about 1 new study participant per day.
Almost all research or self-care apps include BCT elements,
such as prompts/cues to fill in questionnaires (self-monitoring)
or to engage in app- specific intervention components. Dialog
boxes are also used to give feedback on behavior or to promote
self-belief [19]. However, the adequate implementation and the
proper description of the applied BCTs are not easy to achieve.
Therefore, it is important to involve psychologists or behavioral
scientists in the design and development of an app [36,37]. The
review of the use of the BCT taxonomy during the development
of the trial revealed some discrepancies between the study team
members and the psychologists that were involved in the ratings.
For future studies, the behavior change wheel framework by
Michie et al [38] will be applied before the app development
to improve the design and implementation of app-based
interventions [39]. Moreover, the mechanisms and efficacy of
BCTs implemented need to be further explored in mHealth
research settings.
As in our previous mHealth studies, the app and trial
simultaneously shaped each other during the trial design and
app development process. In conventional RCTs, the trial
intervention and outcomes are usually very standardized as they
are described in the study protocol. However, during the
development and coding process of the study app, we regularly
made adaptations of the study protocol because of technical and
design aspects. For example, during the development process,
we realized that the digitally collected data can be used to give
the users an overview of study progress and symptom
improvement that subsequently became part of the intervention
strategy. Branching within a question (the answer of an item
impacts the next question choices) and combining different
question types were not possible with the standard ResearchKit
framework. Moreover, baseline questions had to be limited to
reduce the time spent until finalization of onboarding, that is,
the whole process from introduction, eligibility screening, and
participant consent until completion of baseline survey and the
random allocation to the respective intervention group. However,
the final onboarding process in our research app was longer
than what users of consumer apps might usually accept. This
could have resulted in a loss of potential study participants.
Some baseline questions typical for research studies, such as
questions about partnership and income, were omitted because
of privacy concerns. It was not necessary to collect body weight
and height as PII data, as they were only used for BMI
calculation on the user’s iPhone and not transferred to the study
backend. The study design also impacted some technical
decisions. For instance, to limit recall bias, questions that
required daily answers before and during the period will expire
after 7 days. Moreover, the way symptoms are measured or
tracked in an app is limited to validated and commonly used
outcomes. NRS or Likert scales are used instead of more
consumer-oriented approaches, such as individualized icons or
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emojis to record mood or pain. This might limit the user
experience.
Limitations
In addition to the limitation of the development process already
described above, several other related limitations have to be
taken into account. The decision to focus on Apple’s iOS only
enabled the use of Apple ResearchKit and avoided the
difficulties associated with developing for 2 operating systems
simultaneously, as was done in our previous trials [12,27].
Owing to this decision, only women using an iPhone can
participate in the study, which consequently might introduce
selection bias and therefore limit the generalizability of the
study. Moreover, the impact of technical updates (ie,
ResearchKit and iOS updates) or other potential adaptations of
the app during the course of the study is not clear yet, but these
adaptations will be thoroughly reported in the results paper of
the trial.
Our study is also subject to some limitations from the access
perspective. The numbers of App Store’s visitors and downloads
are generated by Apple’s App Analytics, which we do not
control. This is the only source to estimate the number of
subjects interested in our study because of our anonymous study
design. However, we think that it is important to also include
App Analytics’ data despite its nonstudy purpose. Taking
advantage of these resources from the mHealth ecosystem might
help future app-based studies. To be eligible to use our study
app, individuals who downloaded the app had to pass our
12-question eligibility screening that is based on our relatively
strict inclusion and exclusion criteria. However, for the
assessment of user evolution, we could only record the number
of eligible users who gave consent because of ResearchKit’s
design restrictions and our privacy rules. As a result, we lack
knowledge about the reasons for ineligibility. In addition,
although the participant’s eligibility and survey data underwent
comparably strict plausibility checks that we have implemented
in the app, fake users and fraud registration for the study cannot
be completely ruled out. However, our fully remote study allows
user behavior in a real-life setting [12,21,40]. Additional
plausibility checks will be developed before the analysis of the
results. Another way to access the app could be on
recommendation of a gynecologist and/or family physician
within a therapeutic setting. Further study is required to make
a definite conclusion about the extent to which the app might
be of use in such a setting.
Data on user engagement in our study are limited so far. The
only indicator we currently use for assessing engagement is
based on the completion and response of the baseline questions.
Commercial apps often use analytic tools to track user
interaction with the app. These data can be used for the
evaluation of engagement [41], the optimization of the app, or
the addition of new features. In a study setting with strict privacy
considerations, we do not use these tools. In addition, adherence
would be a good measurement for user engagement. Data about
adherence is not available yet but will be considered as an
outcome of the study.
Comparison With Prior Studies
The study app and the app-based trial result from adaptation
and amendments of our previous AKUD trial [12,27]. The
inclusion criteria of the research population are based on the
previous trial but were modified to meet the necessities of
remote recruitment. In the previous AKUD trial, participants
were recruited through onsite recruitment by 1 study center in
Berlin, Germany facilitated by advertisements (posters, flyers,
leaflets, students email lists, and subway advertisements).
Baseline data were recorded with paper-and-pencil surveys.
This way, it took 20 months to reach the recruitment target of
221 participants [12,27]. With the ResearchKit-based study app,
we are now able to reach participants across Germany.
For the assessment of access of app studies, Anguera et al [40]
reported the recruitment number, whereas Zens et al [14]
reported the consent/download rate. The percentage of consented
participants (27%) in our trial is lower than in other ResearchKit
studies [14,42,43]. The mPower study [42] reported 35%
consent/download rate, whereas the Back on Track study [14]
reported 58%. The differences might be explained by the
observational character of these studies and the application of
a comparably strict eligibility process in our study with 12
eligibility questions.
User adherence and survey response rate are usually considered
to be the measurements for evaluating engagement in app studies
[40,44,45]. However, as adherence data of the current trial are
not available in the current stage of the study, the baseline
survey response is used as a proxy for engagement.
The ResearchKit framework has been used for studies for many
health conditions, such as asthma [43], acute anterior cruciate
ligament ruptures [14], and Parkinson disease [42] since its
launch in 2015 [46]. To our knowledge, no ResearchKit clinical
trial for pain conditions has been conducted yet. Thurnheer et
al [5] reported 15 studies without ResearchKit and their efficacy
in a systematic review of app-based studies for pain
management. App-based studies have been conducted both for
acute pain such as acute needle stick pain [47] and acute pain
before coronarography [48] and for chronic pain such as chronic
cancer pain [49], neck pain [50], and low back pain [24,51]. No
mHealth-based interventional trial has been conducted for
examining the influence of an app promoting health behavior
and the use of acupressure on menstrual pain [5,52] so far.
Regarding the high prevalence of menstrual pain and the
increasing ownership of smartphones [12,53,54], our trial might
provide data that can have practical public health implications.
Conclusions
Conducting an evidence-based and up-to-date app study requires
multidisciplinary efforts. The resulting ResearchKit-based study
app for menstrual pain is accessible for the target population
with positive user engagement. However, future research is
necessary to investigate the determinants of user engagement,
optimal BCT application, and potential clinical scenarios for
app use.
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